NCT06869005Not yet recruiting
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
Prévoir Les NAusées Et Vomissements CHimio Ou Radio-induits Chez Les Enfants/adolescents Traités Pour Un Cancer
Source: ClinicalTrials.gov · Last updated 11 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Chemo- or radiation-induced nausea and vomiting (CRVN) is one of the most frequent and feared side effects. It is a symptom that is few or not at all evaluated. There is a significant discrepancy between the perception of the CRVN symptom by caregivers and the patient's own experience. At present, there is no real consensus to manage CRVN with medication, and CRVN relief is also the subject of heterogeneous practices. The importance of primary prevention of CRVN, before starting the first treatment sequence, has been highlighted to optimize the action of antiemetic treatments and limit the risk of anticipated nausea and vomiting (NV). The investigators' objective is to objectively assess the risk of CRVN in children/adolescents treated for cancer (and thus effectively prevent this symptom).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 19 Jun 2024
- Start date
- 1 Mar 2025
- Primary completion date
- 31 May 2026
- Lead sponsor
- Rennes University Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT06869005
What you commit to
- Study type: Observational
- Planned participants: 150
- From 1 Mar 2025 to the primary completion date, 31 May 2026
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients or legal representatives with French understanding difficulties.
- Patients or legal representatives subject with legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty.
Who the study is looking for
- Treated in a pediatric onco-hematology center in the GOCE (Grand Ouest Cancer Enfant) inter-region;
- Receiving chemotherapy or radiotherapy;
- According to patient age :
- Minor (under 18 years): At least one parent has been informed of the protocol and has not expressed opposition to the child's participation in the study
- Adult (more than 18 years): Having received information about the protocol and not having expressed opposition to participating in the study
Age in the registry: 4 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Angers Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| CHU Caen FEH Coordinator of this site? Confirm its status | Caen | France | Unknown status |
| Rennes University Hospital Coordinator of this site? Confirm its status | Rennes | France | Unknown status |
| Institut de Cancérologie de l'Ouest - René Gauducheau Coordinator of this site? Confirm its status | Saint-Herblain | France | Unknown status |
| CHU Tours Hôpital Clocheville Coordinator of this site? Confirm its status | Tours | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.